These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9340155)

  • 21. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
    Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
    Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Topiramate in the therapy of epilepsy. Complex action mechanism--multiple action].
    Nervenarzt; 1999 Oct; 70(10 Suppl Komplexer):1-4. PubMed ID: 10555524
    [No Abstract]   [Full Text] [Related]  

  • 23. Topiramate in long-term treatment of epilepsy in the intellectually disabled.
    Arvio M; Sillanpää M
    J Intellect Disabil Res; 2005 Mar; 49(Pt 3):183-9. PubMed ID: 15713193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Weight loss with topiramate in patients with epileptic disorders].
    Carnero Fernández M; Morales Gorría MJ; Corredera García E; Del Campo Pérez V
    Med Clin (Barc); 2005 Apr; 124(16):636-7. PubMed ID: 15871784
    [No Abstract]   [Full Text] [Related]  

  • 28. Topiramate: uses in people with an intellectual disability who have epilepsy.
    Kerr MP
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():74-9. PubMed ID: 10030437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of topiramate: a review.
    Garnett WR
    Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroprotective effects of topiramate].
    Pappalardo A; Liberto A; Patti F; Reggio A
    Clin Ter; 2004; 155(2-3):75-8. PubMed ID: 15244111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacy clinics. Medication of the month. Topiramate (Topamax)].
    Sadzot B
    Rev Med Liege; 2000 Feb; 55(2):114-6. PubMed ID: 10769582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. USL255 extended-release topiramate for the treatment of epilepsy.
    Chung S
    Expert Rev Neurother; 2014 Oct; 14(10):1127-37. PubMed ID: 25220748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacology and clinical results of topiramate (TOPINA Tablets), a new antiepileptic drug].
    Kobayashi M; Watanabe M; Nakamura J
    Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):45-52. PubMed ID: 18622103
    [No Abstract]   [Full Text] [Related]  

  • 35. Topiramate effects on plasma serotonin levels in children with epilepsy.
    Grosso S; Blardi P; Battaglini M; Franzoni E; De Lalla A; Mostardini R; Balestri P
    Epilepsy Res; 2008 Oct; 81(2-3):148-54. PubMed ID: 18603411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials.
    Jung KY; Cho JW; Joo EY; Kim SH; Choi KM; Chin J; Park KW; Hong SB
    Clin Neurophysiol; 2010 Sep; 121(9):1494-1501. PubMed ID: 20678718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risks and benefits of new antiepileptic agents in children].
    Aicardi J
    Rev Neurol; 2000 Aug 16-31; 31(4):376-81. PubMed ID: 11008295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Challenges in epilepsy therapy: start low, go slow. 72nd Congress of the German Society for Neurology. Topiramate--a valuable new tool for the therapy of focal epilepsy? 1 October 1999, Magdeburg].
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12 Suppl Herausford):1-4. PubMed ID: 10686677
    [No Abstract]   [Full Text] [Related]  

  • 40. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.